home / stock / pmedf / pmedf news

PMEDF News and Press, Predictmedix Inc From 07/25/22

Stock Information
Company Name: Predictmedix Inc
Stock Symbol: PMEDF
Market: OTC
Website: predictmedix.com
Menu
PMEDF PMEDF Quote PMEDF Short PMEDF News PMEDF Articles PMEDF Message Board
Get PMEDF Alerts

News, Short Squeeze, Breakout and More Instantly...
PMEDF - Predictmedix Announces Accuracy Rates for Monitoring of Symptoms and Physiological Parameters

TORONTO, ON / ACCESSWIRE / July 25, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced its accuracy rates for identifying Respir...
PMEDF - Predictmedix Receives $1.85 Million Letter of Intent for 80 Safe Entry Stations from KaTron Defence Space and Simulation Technologies

TORONTO, ON / ACCESSWIRE / June 29, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced that it has received a non-binding Lett...

PMEDF - Predictmedix Secures Deployment of Safe Entry Stations at De Beers Forevermark Forum 2022

High Visibility, Revenue Generating Deployment Provides Predictmedix with Strong Industry Validation TORONTO, ON / ACCESSWIRE / June 15, 2022 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered...

PMEDF - Predictmedix Inc. GAAP EPS of -C$0.01, revenue of C$134.82M

Predictmedix Inc. press release (OTCQB:PMEDF): FY GAAP EPS of -C$0.01. Revenue of C$134.82M. For further details see: Predictmedix Inc. GAAP EPS of -C$0.01, revenue of C$134.82M

PMEDF - Predictmedix Reports Fiscal 2022 Financial Results

TORONTO, ON / ACCESSWIRE / June 1, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today reported its financial and operational results for t...

PMEDF - Predictmedix to Present at 12th Annual LD Micro Invitational

Interim CEO Dr. Rahul Kushwah to Present at 11:00 a.m. Pacific on June 7, 2022 TORONTO, ON / ACCESSWIRE / May 24, 2022 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a proprietary artific...

PMEDF - Predictmedix Showcases Safe Entry Station Technology at Major Las Vegas Entertainment Event

Placement at Major Las Vegas Venue Served as Live, High-Profile Demonstration of Safe Entry Station to Area Entertainment and Hospitality Sector Representative s TORONTO, ON / ACCESSWIRE / April 5, 2022 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the "Company"), an...
PMEDF - Predictmedix Inc. Issues Shareholder Letter and Provides Corporate Update on Key Milestone Achievements

TORONTO, ON / ACCESSWIRE / February 10, 2022 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today released a letter to shareholders from Interim Chi...

PMEDF - Predictmedix To Launch Infectious Diseases Clinical Trial in North American Hospital for FDA Medical Device Classification of Safe Entry Stations

Independent Study for Infectious Diseases Symptom Detection in a Clinical Setting to Provide Additional Third-Party Validation; Prerequisite Ahead of Planned FDA Certification as Class II Medical Device TORONTO, ON / ACCESSWIRE / January 26, 2022 / Predictmedix Inc. (CSE:PMED)(OTCQB:PME...

PMEDF - Predictmedix Announces Accuracy Rates for Alcohol and Cannabis Impairment Detection Technology and Provides Update on the Next Steps for Technology Commercialization

Upcoming Clinical trial in North American Hospital Expected to Provide Additional Third-Party Validation Ahead of Planned Commercial Launch TORONTO, ON / ACCESSWIRE / January 12, 2022 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of ...
Previous 10 Next 10